David Elsley

Founder at CARDIOL THERAPEUTICS INC.

Net worth: 2 M $ as of 2026-05-30

Health Technology

Consumer Services

Profile

David G.
Elsley was the founder of Vasogen, Inc., founded in 1990, where the title held was Director from 1990 to 2009.
Mr. Elsley is the founder of Cardiol Therapeutics, Inc., founded in 2017, holding the titles of President, Chief Executive Officer & Director since 2017.
Mr. Elsley completed an MBA degree at Richard Ivey School of Business.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CARDIOL THERAPEUTICS INC. CLASS A 1.2%	2025-12-29	1,344,500 ( 1.2% )	2 M $	2026-05-30

David Elsley active positions

Companies	Position	Start
CARDIOL THERAPEUTICS INC.	Founder	2017-01-18

All active positions of David Elsley

Former positions of David Elsley

Companies	Position	End
Vasogen, Inc. Vasogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat cardiovascular and neurodegenerative disorders	Founder	2009-10-22

See the detail of David Elsley's experience

Training of David Elsley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Elsley's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Vasogen, Inc. Vasogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat cardiovascular and neurodegenerative disorders	Health Technology
Richard Ivey School of Business Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cardiol Therapeutics, Inc. Cardiol Therapeutics, Inc. BiotechnologyHealth Technology Operates as a life sciences company that researches and develops antifibrotic and anti-inflammatory therapy for the treatment of cardiovascular disease	Health Technology